tylophorine has been researched along with Colitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Cheng, H; Guo, W; Hong, Z; Wang, J; Wu, Z; Yin, Z; Yu, M; Zhao, L; Zhao, Q | 1 |
Gao, X; Han, J; He, X; Hong, Z; Huo, X; Jia, Z; Meng, X; Tian, G; Wang, P; Wang, Q; Wang, Z; Wu, M; Wu, Z; Xiong, S; Yin, Z; Zhang, Y; Zhao, L; Zhou, X | 1 |
2 other study(ies) available for tylophorine and Colitis
Article | Year |
---|---|
Targeted delivery of NK007 to macrophages to treat colitis.
Topics: Alginates; Alkaloids; Animals; Anti-Inflammatory Agents; Chemistry, Pharmaceutical; Chitosan; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Indolizines; Macrophages; Mice; Pharmaceutical Preparations; Phenanthrenes | 2015 |
A novel tylophorine analog W-8 up-regulates forkhead boxP3 expression and ameliorates murine colitis.
Topics: Alkaloids; Animals; Blotting, Western; Colitis; Disease Models, Animal; Forkhead Transcription Factors; Indolizines; Lymphocyte Activation; Mice; Phenanthrenes; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; T-Lymphocytes, Regulatory; Up-Regulation | 2013 |